Up until spring 2019, Dr. Jane Osbourn OBE was vice president of R&D and site leader for AstraZeneca PLC’s MedImmune unit in Cambridge, UK. She is now working on several smaller biotech projects, one of which focuses scientific thinking around why people are well to inform R&D for new approaches to treating disease.
Osbourn, an expert in antibody engineering, was involved in the discovery of the world’s best-selling drug, Humira. She has authored...